… acquired drug resistance to NRTIs in Southern Africa among patients failing first-line ART and
… estimate the occurrence of several drug resistance mutations accounting for different study …

… in addition to sorafenib demonstrated a survival benefit in phase III clinical trials, which
include lenvatinib as first line, and regorafenib, cabozantinib, and ramucirumab as second …

… was estimated to be 5.6%,11 resistance to firstline drugs has steadily increased to 8.3% in …
drug resistance survey. Our objective was to estimate the proportion of drug resistance among …

… basis for evolution of Mtb drug resistance. This narrative and traditional … and drug resistance
mechanisms in Mtb. The aim of this review is to provide recent updates on drug resistance …

… The two main problems in prevention tuberculosis is the late and incomplete diagnosis
and the drug resistance of the First Line and Second Line Drugs. In this paper, we have …

… In the current review we ask: Are drug resistance mechanisms that emerge following … lead
to the same drug resistance modality? This question portends critical drug treatment decisions (…

… These observations led to additional drug discovery efforts to target the drug resistance
L119M mutation. In addition, a wider range of drug resistant mutations were observed such as …

… drug susceptibility testing (pDST) to guide anti-TB therapies minimizes the risk of developing
resistance … tuberculosis routine pDST and drug resistance surveillance (DRS) are the solid-…

… In this study, a comprehensive database describing drug resistance information named ‘…
, for the first time, all existing types of molecular mechanisms underlying drug resistance, (ii) …

… Here, we present our study of MTB drug resistance classification using traditional ML
methods (LR and RF) and a deep neural network architecture of 1D CNN on a large and diverse …